Early Lapatinib-Induced Skin Rash Predicts Better Survival With

Early development of skin rash following lapatinib and trastuzumab therapy is associated with improved survival.

/files/Articles/600573/fonc-10

PDF] Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO

Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal

Wendy A. Woodward, M.D., Ph.D., Radiation Oncologist

HER-2 directed therapy in advanced breast cancer

Clinical management of cutaneous adverse events in patients on

Multicenter Phase II Study of Neoadjuvant Lapatinib and

Page 1529 – Cancer Therapy Advisor

HER2-positive breast cancer and tyrosine kinase inhibitors: the

Frontiers Exceptional and Durable Responses to TDM-1 After

Phase II Study of Predictive Biomarker Profiles for Response

Page 1526 – Cancer Therapy Advisor

Update on systemic treatment for newly diagnosed inflammatory

Cutaneous toxicities from targeted therapies used in oncology

Inflammatory breast cancer rash??

Breastfeeding and rashes on breasts: Understanding the causes and

My breast implants made me suffer for years with mystery illness

CoppaFeel! on X: Inflammatory breast cancer is a rare type of breast cancer which may cause the skin on the breast to look red or inflamed. The symptoms are caused by cancer

Early Lapatinib-Induced Skin Rash Predicts Better Survival With Lapatinib+Trastuzumab Therapy - Cancer Therapy Advisor